![]() Frankly, when it comes to medical advice about the pandemic, Marshall is out of his depth. He and his wife, Laina, have been married for 32. His visit coincided with renewal of questions about abortion in the campaign pitting Marshall against Democratic nominee Barbara Bollier. It should be noted that while Marshall is a medical professional, he’s an obstetrician and gynecologist, not an epidemiologist or a virologist. Roger Marshall, Congressman for Kansas’ Big 1st District, is a physician, and devoted father and husband. Senate candidate Roger Marshall greets supporters during a campaign stop Tuesday in Topeka. In August, Marshall questioned the effectiveness of masking. This isn’t the first time Marshall has been opposed to what Fauci and the CDC have advised. More: 'It probably even makes it worse': Sen. Fauci is often a target of Republican criticism. 18, 2021, at the National Agricultural Center and Hall of Fame, in Wyandotte County. The pressure on Fauci was under was politically motivated. Kansas Senator Roger Marshall spoke at a town hall meeting Saturday morning, Sept. It seems like playground antics playing out on a national level. "Calling me a moron during a Senate hearing may have alleviated the stress of the least trusted bureaucrat in America, but it didn’t take away from the facts," Marshall said in a statement. Marshall also grilled Fauci on other things relating to the coronavirus, such as why officials weren't investing more in pushing out therapeutics to treat COVID-19. It seems like Marshall was grasping at straws here.īahl reported media outlets, including the Center for Public Integrity, have obtained Fauci's financial disclosure information in past years. "My financial disclosures are public knowledge and have been so. This bill seeks to disrupt that incentive and lower drug costs by delinking PBM’s revenue streams from the list price of drugs."What are you talking about?" Fauci interjected. Right now PBMs make less money from lower-cost drugs and they often get left off formularies and aren’t covered by insurance. Instead of incentivizing PBMs to buy and sell the most expensive drugs by linking their service fees to the list price of drugs, this bill would only allow PBMs to charge a flat fee for their services. This bill would do just that and is a step in the right direction to helping more Americans afford the lifesaving medications they need.” “One way we can help lower drug prices is by removing incentives for pharmacy benefit managers to prefer medications with high list prices. “Too many Americans aren’t able to afford critical medications like insulin because of the high costs of prescription drugs,” said Kaine. Congress needs to pass our bill and put patients over profits.” Our bipartisan legislation delinks administrative fees paid to PBMs from the price of medicines, and I’m proud to partner with my colleagues to advance this legislation. This ultimately leaves patients, the most important group in all of health care, with less choices and higher costs. “Worst of all, PBMs discriminate against generic or lower-cost brand competitors. This is a perverse incentive that favors prescription drugs with higher list prices,” Senator Marshall said. “PBM’s business model revolves around payments as a percentage of the cost of medicine. That’s why I worked with my colleagues on a bill to lower drug costs and inject some transparency into the market once and for all, and I won’t stop fighting until we get it passed.” “For too long, massive PBMs have been price gouging consumers with bad incentives and hidden fees, and it’s about time we hold these massive corporations accountable. “When Montanans are having to decide between buying a bag of groceries and picking up their life-saving prescriptions, we’ve got a real problem,” said Tester. The Senators’ bill would prohibit PBMs from making more money on high-cost drugs than they do from lower-cost drugs to even the playing field for patients. ![]() ![]() Senators Jon Tester (D-MT), Roger Marshall (R-KS), and Tim Kaine (D-VA) today introduced their bipartisan Delinking Revenue from Unfair Gouging (DRUG) Act to lower drug costs and prevent massive Pharmacy Benefit Managers (PBMs) from price gouging consumers. ![]()
0 Comments
Leave a Reply. |